CLINICAL_TRIALS
trial_result
· 2014-09-22
Clinical Trial Update: Efficacy and Safety of IBI-10090 in Ocular Surgery Patients [Phase 2]
Summary
Phase 2 trial evaluating the efficacy and safety of IBI-10090 in inflammation following cataract surgery. Results have been completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ICON Bioscience Inc | Conditions: Inflammation Associated With Cataract Surgery | Phase 2 | Status: COMPLETED | Results posted: 2014-09-22